CROSS CTRY HEALTHCARE INC's ticker is CCRN and the CUSIP is 227483104. A total of 198 filers reported holding CROSS CTRY HEALTHCARE INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,956,672 | -33.9% | 148,915 | -29.5% | 0.02% | -32.4% |
| Q3 2022 | $5,989,000 | +264.7% | 211,099 | +167.8% | 0.03% | +240.0% |
| Q2 2022 | $1,642,000 | -31.0% | 78,836 | -28.2% | 0.01% | -50.0% |
| Q1 2022 | $2,379,000 | +10.0% | 109,802 | +41.0% | 0.02% | -4.8% |
| Q4 2021 | $2,162,000 | +47.9% | 77,876 | +13.2% | 0.02% | +16.7% |
| Q3 2021 | $1,462,000 | +32.4% | 68,817 | +2.9% | 0.02% | +50.0% |
| Q2 2021 | $1,104,000 | +70.4% | 66,855 | +28.9% | 0.01% | +50.0% |
| Q1 2021 | $648,000 | +94.0% | 51,862 | +37.8% | 0.01% | +60.0% |
| Q4 2020 | $334,000 | -4.6% | 37,634 | -30.2% | 0.01% | 0.0% |
| Q3 2020 | $350,000 | +91.3% | 53,884 | +81.3% | 0.01% | +66.7% |
| Q2 2020 | $183,000 | -79.2% | 29,715 | -60.7% | 0.00% | -81.2% |
| Q4 2019 | $879,000 | +257.3% | 75,686 | +403.5% | 0.02% | +14.3% |
| Q4 2015 | $246,000 | -72.2% | 15,031 | -76.9% | 0.01% | -68.9% |
| Q3 2015 | $886,000 | +421.2% | 65,098 | +353.9% | 0.04% | +462.5% |
| Q1 2015 | $170,000 | +18.9% | 14,342 | +25.0% | 0.01% | 0.0% |
| Q4 2014 | $143,000 | – | 11,478 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 87,019 | $772,000 | 0.98% |
| Sio Capital Management, LLC | 485,164 | $4,303,000 | 0.88% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 2,100,084 | $18,628,000 | 0.82% |
| HEARTLAND ADVISORS INC | 951,898 | $8,443,000 | 0.60% |
| National Investment Services of America, LLC | 33,744 | $299,000 | 0.53% |
| Aristotle Capital Boston, LLC | 2,473,371 | $21,939,000 | 0.52% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 235,009 | $2,085,000 | 0.45% |
| C M BIDWELL & ASSOCIATES LTD | 33,900 | $301,000 | 0.25% |
| OBERWEIS ASSET MANAGEMENT INC/ | 63,800 | $566,000 | 0.15% |
| ROYCE & ASSOCIATES LP | 1,772,675 | $15,724,000 | 0.13% |